Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche.

Shinde A, Paez JS, Libring S, Hopkins K, Solorio L, Wendt MK.

Oncogenesis. 2020 Feb 13;9(2):16. doi: 10.1038/s41389-020-0204-5.

PMID:
32054828
2.

Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases.

Uzunalli G, Dieterly AM, Kemet CM, Weng HY, Soepriatna AH, Goergen CJ, Shinde AB, Wendt MK, Lyle LT.

Oncotarget. 2019 Oct 29;10(59):6334-6348. doi: 10.18632/oncotarget.27274. eCollection 2019 Oct 29.

3.

Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells.

Cai B, Kim D, Akhand S, Sun Y, Cassell RJ, Alpsoy A, Dykhuizen EC, Van Rijn RM, Wendt MK, Krusemark CJ.

J Am Chem Soc. 2019 Oct 30;141(43):17057-17061. doi: 10.1021/jacs.9b08085. Epub 2019 Oct 22.

PMID:
31613623
4.

Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.

Krabill AD, Chen H, Hussain S, Feng C, Abdullah A, Das C, Aryal UK, Post CB, Wendt MK, Galardy PJ, Flaherty DP.

Chembiochem. 2019 Aug 26. doi: 10.1002/cbic.201900434. [Epub ahead of print]

PMID:
31449350
5.

Application of a Substrate-Mediated Selection with c-Src Tyrosine Kinase to a DNA-Encoded Chemical Library.

Kim D, Sun Y, Xie D, Denton KE, Chen H, Lin H, Wendt MK, Post CB, Krusemark CJ.

Molecules. 2019 Jul 30;24(15). pii: E2764. doi: 10.3390/molecules24152764.

6.

PBRM1 Regulates Stress Response in Epithelial Cells.

Porter EG, Dhiman A, Chowdhury B, Carter BC, Lin H, Stewart JC, Kazemian M, Wendt MK, Dykhuizen EC.

iScience. 2019 May 31;15:196-210. doi: 10.1016/j.isci.2019.04.027. Epub 2019 Apr 26.

7.

Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.

Shinde A, Hardy SD, Kim D, Akhand SS, Jolly MK, Wang WH, Anderson JC, Khodadadi RB, Brown WS, George JT, Liu S, Wan J, Levine H, Willey CD, Krusemark CJ, Geahlen RL, Wendt MK.

Cancer Res. 2019 Apr 15;79(8):1831-1843. doi: 10.1158/0008-5472.CAN-18-2636. Epub 2019 Feb 7.

PMID:
30733195
8.

Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand.

Ali R, Brown W, Purdy SC, Davisson VJ, Wendt MK.

Cell Death Dis. 2018 Sep 24;9(10):976. doi: 10.1038/s41419-018-1034-7.

9.

Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.

Leng Y, Abdullah A, Wendt MK, Calve S.

Matrix Biol. 2019 May;78-79:236-254. doi: 10.1016/j.matbio.2018.08.008. Epub 2018 Aug 18.

PMID:
30130585
10.

Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer.

Shinde A, Wilmanski T, Chen H, Teegarden D, Wendt MK.

Breast Cancer Res. 2018 Jul 13;20(1):76. doi: 10.1186/s13058-018-1008-9.

11.

Autocrine Fibronectin Inhibits Breast Cancer Metastasis.

Shinde A, Libring S, Alpsoy A, Abdullah A, Schaber JA, Solorio L, Wendt MK.

Mol Cancer Res. 2018 Oct;16(10):1579-1589. doi: 10.1158/1541-7786.MCR-18-0151. Epub 2018 Jun 22.

12.

Analytical Pipeline for Discovery and Verification of Glycoproteins from Plasma-Derived Extracellular Vesicles as Breast Cancer Biomarkers.

Chen IH, Aguilar HA, Paez Paez JS, Wu X, Pan L, Wendt MK, Iliuk AB, Zhang Y, Tao WA.

Anal Chem. 2018 May 15;90(10):6307-6313. doi: 10.1021/acs.analchem.8b01090. Epub 2018 Apr 23.

PMID:
29629753
13.

Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy.

Hardy SD, Shinde A, Wang WH, Wendt MK, Geahlen RL.

Oncotarget. 2017 Oct 17;8(61):103302-103314. doi: 10.18632/oncotarget.21871. eCollection 2017 Nov 28.

14.

Selective Inhibition of STAT3 Phosphorylation Using a Nuclear-Targeted Kinase Inhibitor.

Bartolowits MD, Brown W, Ali R, Pedley AM, Chen Q, Harvey KE, Wendt MK, Davisson VJ.

ACS Chem Biol. 2017 Sep 15;12(9):2371-2378. doi: 10.1021/acschembio.7b00341. Epub 2017 Aug 18.

15.

The paradoxical functions of EGFR during breast cancer progression.

Ali R, Wendt MK.

Signal Transduct Target Ther. 2017;2. pii: 16042. doi: 10.1038/sigtrans.2016.42. Epub 2017 Jan 20.

16.

Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.

Chen IH, Xue L, Hsu CC, Paez JS, Pan L, Andaluz H, Wendt MK, Iliuk AB, Zhu JK, Tao WA.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180. doi: 10.1073/pnas.1618088114. Epub 2017 Mar 7.

17.

FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.

Brown WS, Akhand SS, Wendt MK.

Oncotarget. 2016 Dec 13;7(50):83424-83436. doi: 10.18632/oncotarget.13117.

18.

Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.

Brown WS, Tan L, Smith A, Gray NS, Wendt MK.

Mol Cancer Ther. 2016 Sep;15(9):2096-106. doi: 10.1158/1535-7163.MCT-16-0136. Epub 2016 Jul 1.

19.

Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.

Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour D, Sossey-Alaoui K, Schiemann WP.

Neoplasia. 2015 Mar;17(3):317-28. doi: 10.1016/j.neo.2015.02.003.

20.

The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.

Wendt MK, Williams WK, Pascuzzi PE, Balanis NG, Schiemann BJ, Carlin CR, Schiemann WP.

Neoplasia. 2015 Jan;17(1):124-33. doi: 10.1016/j.neo.2014.11.009.

Supplemental Content

Loading ...
Support Center